MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jcmg.2024.05.002

Медицинская библиотека · JACC. Cardiovascular imaging · 2024

Prognostic Value of Left Ventricular 18F-Florbetapir Uptake in Systemic Light-Chain Amyloidosis.

Clerc Olivier F, Datar Yesh, Cuddy Sarah A M, Bianchi Giada, Taylor Alexandra, Benz Dominik C, Robertson Matthew, Kijewski Marie Foley, Jerosch-Herold Michael, Kwong Raymond Y, Ruberg Frederick L, Liao Ronglih, Di Carli Marcelo F, Falk Rodney H, Dorbala Sharmila

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Positron emission tomography/computed tomography (PET/CT) with 18F-florbetapir, a novel amyloid-targeting radiotracer, can quantify left ventricular (LV) amyloid burden in systemic light-chain (AL) amyloidosis. However, its prognostic value is not known.

OBJECTIVES

The authors' aim was to evaluate the prognostic value of LV amyloid burden quantified by 18F-florbetapir PET/CT, and to identify mechanistic pathways mediating its association with outcomes.

METHODS

A total of 81 participants with newly diagnosed AL amyloidosis underwent 18F-florbetapir PET/CT imaging. Amyloid burden was quantified using 18F-florbetapir LV uptake as percent injected dose. The Mayo stage for AL amyloidosis was determined using troponin T, N-terminal pro-B-type natriuretic peptide (NT-proBNP), and free light chain levels. Major adverse cardiac events (MACE) were defined as all-cause death, heart failure hospitalization, or cardiac transplantation within 12 months.

RESULTS

Among participants (median age, 61 years; 57% males), 36% experienced MACE, increasing from 7% to 63% across tertiles of LV amyloid burden (P < 0.001). LV amyloid burden was associated with MACE (HR: 1.46; 95% CI: 1.16-1.83; P = 0.001). However, this association became nonsignificant when adjusted for Mayo stage. In mediation analysis, the association between LV amyloid burden and MACE was mediated by NT-proBNP (P < 0.001), a marker of cardiomyocyte stretch and heart failure, and a component of Mayo stage.

CONCLUSIONS

In this first study to link cardiac 18F-florbetapir uptake to subsequent outcomes, LV amyloid burden estimated by percent injected dose predicted MACE in AL amyloidosis. This effect was not independent of Mayo stage and was mediated primarily through NT-proBNP. These findings provide novel insights into the mechanism linking myocardial amyloid deposits to MACE.

Для цитирования: Clerc Olivier F, Datar Yesh, Cuddy Sarah A M, Bianchi Giada, Taylor Alexandra, Benz Dominik C, Robertson Matthew, Kijewski Marie Foley, Jerosch-Herold Michael, Kwong Raymond Y, Ruberg Frederick L, Liao Ronglih, Di Carli Marcelo F, Falk Rodney H, Dorbala Sharmila. Prognostic Value of Left Ventricular 18F-Florbetapir Uptake in Systemic Light-Chain Amyloidosis.. JACC. Cardiovascular imaging. 2024. DOI: 10.1016/j.jcmg.2024.05.002.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.